Dec 12, 2023 / 03:00PM GMT
Operator
Lacutamab KOL event. (Operator Instructions) I'll now turn the conference over to Henry Wheeler, VP of Investor Relations and Communication. Please go ahead.
Henry Wheeler Innate Pharma SA-VP - IR & Communications
Thank you. Good morning, good afternoon, and welcome, everyone. Thank you for joining today's Innate KOL call on lacutamab where we look forward to sharing updates from data presented at ASH here in San Diego over the weekend. Today's presentation is available on the IR section of our website.
On slide 2, before we start, I would like to remind you that we will be making forward-looking statements regarding the financial outlook in addition to product developments. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted.
On slide 3, on today's call, we will be joined by Dr. Sonia Quaratino, our Chief Medical Officer. And we'd also like to thank Dr. Porcu, Director, Division of Hematological Malignancies and Hematopoietic Stem Cell Transplantation,
Innate Pharma SA KOL Event Transcript
Dec 12, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers